BIOMAT Database Logo BIOMAT Database Logo

Successful non-T-cell-depleted HLA-haploidentical 3-loci mismatched bone marrow transplantation. 2005

Shigeki Yagyu, and Hiroshi Kuroda, and Atsushi Fujiki, and Shinichi Tamura, and Tomoko Iehara, and Akira Morimoto, and Hajime Hosoi, and Tohru Sugimoto, and Shinsaku Imashuku
Department of Pediatrics, Kyoto City Hospital, Kyoto, Japan. shigeky@m7.dion.ne.jp

A 17-year-old boy with therapy-related acute myelocytic leukemia (FAB classification-M0) successfully received allogeneic non-T-cell depleted (non-TCD) bone marrow transplantation (BMT) from his 3-loci HLA-mismatch mother, although pre-BMT detection of feto-maternal microchimerism was negative. The BMT was performed with reduced intensity conditioning (total body irradiation; 4 Gy, fludarabine; 20 mg/m(2) x 6, and melphalan; 70 mg/m(2) x 2) and short-course methotrexate and tacrolimus for GVHD prophylaxis. Complete donor chimera was obtained on day 19, associated with Grade 3 acute GVHD (skin: Stage 1, liver: Stage 0, gut: Stage 3) that was well controlled with immunosuppressive therapies. At day 200 of transplantation, he was in complete remission with no signs of chronic GVHD. Our case suggests that non-TCD HLA-haploidentical 3-loci mismatched BMT can be safely performed from mother to offspring even when feto-maternal microchimerism is barely detectable with the current detection procedure.

UI MeSH Term Description Entries
D008297 Male Males
D009035 Mothers Female parents, human or animal. Mothers' Clubs,Club, Mothers',Clubs, Mothers',Mother,Mother Clubs,Mother's Clubs,Mothers Clubs,Mothers' Club
D012074 Remission Induction Therapeutic act or process that initiates a response to a complete or partial remission level. Induction of Remission,Induction, Remission,Inductions, Remission,Remission Inductions
D005260 Female Females
D006086 Graft vs Host Disease The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION. Graft-Versus-Host Disease,Homologous Wasting Disease,Runt Disease,Graft-vs-Host Disease,Disease, Graft-Versus-Host,Disease, Graft-vs-Host,Disease, Homologous Wasting,Disease, Runt,Diseases, Graft-Versus-Host,Diseases, Graft-vs-Host,Graft Versus Host Disease,Graft-Versus-Host Diseases,Graft-vs-Host Diseases
D006650 Histocompatibility Testing Identification of the major histocompatibility antigens of transplant DONORS and potential recipients, usually by serological tests. Donor and recipient pairs should be of identical ABO blood group, and in addition should be matched as closely as possible for HISTOCOMPATIBILITY ANTIGENS in order to minimize the likelihood of allograft rejection. (King, Dictionary of Genetics, 4th ed) Crossmatching, Tissue,HLA Typing,Tissue Typing,Crossmatchings, Tissue,HLA Typings,Histocompatibility Testings,Testing, Histocompatibility,Testings, Histocompatibility,Tissue Crossmatching,Tissue Crossmatchings,Tissue Typings,Typing, HLA,Typing, Tissue,Typings, HLA,Typings, Tissue
D006680 HLA Antigens Antigens determined by leukocyte loci found on chromosome 6, the major histocompatibility loci in humans. They are polypeptides or glycoproteins found on most nucleated cells and platelets, determine tissue types for transplantation, and are associated with certain diseases. Human Leukocyte Antigen,Human Leukocyte Antigens,Leukocyte Antigens,HL-A Antigens,Antigen, Human Leukocyte,Antigens, HL-A,Antigens, HLA,Antigens, Human Leukocyte,Antigens, Leukocyte,HL A Antigens,Leukocyte Antigen, Human,Leukocyte Antigens, Human
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D014019 Tissue Donors Individuals supplying living tissue, organs, cells, blood or blood components for transfer or transplantation to histocompatible recipients. Organ Donors,Donors,Ovum Donors,Semen Donors,Transplant Donors,Donor,Donor, Organ,Donor, Ovum,Donor, Semen,Donor, Tissue,Donor, Transplant,Donors, Organ,Donors, Ovum,Donors, Semen,Donors, Tissue,Donors, Transplant,Organ Donor,Ovum Donor,Semen Donor,Tissue Donor,Transplant Donor

Related Publications

Shigeki Yagyu, and Hiroshi Kuroda, and Atsushi Fujiki, and Shinichi Tamura, and Tomoko Iehara, and Akira Morimoto, and Hajime Hosoi, and Tohru Sugimoto, and Shinsaku Imashuku
Allogeneic bone marrow transplantation with non-T-cell-depleted marrow from two HLA-antigen-mismatched related donors.
March 2004, Haematologica,
Shigeki Yagyu, and Hiroshi Kuroda, and Atsushi Fujiki, and Shinichi Tamura, and Tomoko Iehara, and Akira Morimoto, and Hajime Hosoi, and Tohru Sugimoto, and Shinsaku Imashuku
Renal transplantation without chronic immunosuppression after T cell-depleted, HLA-mismatched bone marrow transplantation.
June 1995, Transplantation,
Shigeki Yagyu, and Hiroshi Kuroda, and Atsushi Fujiki, and Shinichi Tamura, and Tomoko Iehara, and Akira Morimoto, and Hajime Hosoi, and Tohru Sugimoto, and Shinsaku Imashuku
Bone marrow 'boosts' following T cell-depleted haploidentical bone marrow transplantation.
April 1996, Bone marrow transplantation,
Shigeki Yagyu, and Hiroshi Kuroda, and Atsushi Fujiki, and Shinichi Tamura, and Tomoko Iehara, and Akira Morimoto, and Hajime Hosoi, and Tohru Sugimoto, and Shinsaku Imashuku
Transplantation of T-lymphocyte-depleted bone marrow between HLA-mismatched individuals.
October 1983, Transplantation,
Shigeki Yagyu, and Hiroshi Kuroda, and Atsushi Fujiki, and Shinichi Tamura, and Tomoko Iehara, and Akira Morimoto, and Hajime Hosoi, and Tohru Sugimoto, and Shinsaku Imashuku
Monoclonal antibody T-cell-depleted HLA-haploidentical bone marrow transplantation for Wiskott-Aldrich syndrome.
February 1990, Blood,
Shigeki Yagyu, and Hiroshi Kuroda, and Atsushi Fujiki, and Shinichi Tamura, and Tomoko Iehara, and Akira Morimoto, and Hajime Hosoi, and Tohru Sugimoto, and Shinsaku Imashuku
Transient hemopoietic stem cell engraftment after transplantation of HLA-haploidentical, T-cell-depleted bone marrow.
January 1987, Transplantation,
Shigeki Yagyu, and Hiroshi Kuroda, and Atsushi Fujiki, and Shinichi Tamura, and Tomoko Iehara, and Akira Morimoto, and Hajime Hosoi, and Tohru Sugimoto, and Shinsaku Imashuku
[T cell non-depleted bone marrow transplantation for primary refractory erythroleukemia using a partially HLA-mismatched related donor].
July 1999, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Shigeki Yagyu, and Hiroshi Kuroda, and Atsushi Fujiki, and Shinichi Tamura, and Tomoko Iehara, and Akira Morimoto, and Hajime Hosoi, and Tohru Sugimoto, and Shinsaku Imashuku
Immunoreconstitution in severe combined immunodeficiency after transplantation of HLA-haploidentical, T-cell-depleted bone marrow.
April 1984, Lancet (London, England),
Shigeki Yagyu, and Hiroshi Kuroda, and Atsushi Fujiki, and Shinichi Tamura, and Tomoko Iehara, and Akira Morimoto, and Hajime Hosoi, and Tohru Sugimoto, and Shinsaku Imashuku
Successful treatment of refractory T-cell acute lymphoblastic leukemia by unmanipulated stem cell transplantation from an HLA 3-loci mismatched (haploidentical) sibling.
March 2003, Bone marrow transplantation,
Shigeki Yagyu, and Hiroshi Kuroda, and Atsushi Fujiki, and Shinichi Tamura, and Tomoko Iehara, and Akira Morimoto, and Hajime Hosoi, and Tohru Sugimoto, and Shinsaku Imashuku
HLA non-identical T-cell-depleted bone marrow transplantation for primary immunodeficiency diseases.
February 1994, Australian and New Zealand journal of medicine,
Copied contents to your clipboard!